Recent Transactions

13-Oct-16
$NA
usa_canada.gif
Target: 

Concordia International Corp

flag not available

Advised the Special Committee of the Board of Directors of Concordia International, a diverse, international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs, on its strategic review process

05-Oct-16
$775 million
uk-ireland_35558.gif
Target: 

Assets and operations of Actavis Generics in the UK and Ireland from Teva Pharmaceutical Industries Ltd.

india.gif
Acquiror: 
Accord Healthcare Ltd.

Advising Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on its sale of assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Limited) for £603m (c.$775m) 

05-Oct-16
Pending
$NA
israel.gif
Target: 

Portfolio of 14 Outlicensing generic products in the EEA from Teva Pharmaceutical Industries Ltd.

india.gif
Acquiror: 
Accord Healthcare Ltd.

Advising Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on the divestment of a portfolio of 14 Outlicensing pharmaceutical products in the EEA to Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Limited).

04-Oct-16
$223 million
usa_uk.gif
Target: 

U.S. rights to Toprol-XL (AstraZeneca)

canada.gif
Acquiror: 
Aralez Pharmaceuticals Inc.

Advised Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company in connection with the financing of its acquisition of the U.S. rights to cardiovascular drug Toprol-XL (metoprolol succinate) and its Authorized Generic from AstraZeneca.

04-Oct-16
$32.0 billion
U.S.A. flag
Target: 

Texas Competitive Electric Holdings and its subsidiaries

flag not available

Advised  Texas Competitive Electric Holdings,  Texas’ largest power generator and competitive retail electricity provider, and its subsidiaries at the direction of its independent director in connection with its and Energy Future Holdings’ Chapter 11 proceedings 

29-Sep-16
$628 million
niederland.gif
Target: 

van Gansewinkel Groep BV

uk.gif
Acquiror: 
Shanks Group plc

Advising Shanks Group plc, a leading international waste to product business, on the proposed merger with van Gansewinkel Groep BV, one of the leading waste management service providers, recyclers and suppliers of high-quality secondary raw materials in the Benelux region.

07-Sep-16
Pending
$NA
U.S.A. flag
Target: 

TEGNA, Inc.

flag not available

Advising TEGNA, Inc., a major broadcasting and digital marketing services company, on the spin-off of Cars.com and the creation of two independent publicly traded companies: one focused on television broadcasting and one focused on the online automotive marketplace.

18-Aug-16
Pending
$3.2 billion
switzerland.gif
Target: 

Valves & Controls Business of Pentair

U.S.A. flag
Acquiror: 
Emerson

Advising Emerson, a diversified global technology and industrial company, on the acquisition of the Valves & Controls business of Pentair

09-Aug-16
$NA
australia.gif
Target: 

Bionomics Limited

flag not available

Advised ASX-listed Bionomics, a clinical stage biopharmaceutical company focused on the treatment of serious central nervous system disorders and cancer, on a consultation process with shareholders following calls for Board change, leading to the formation of a shareholder working group of leading institutional investors and company-led Board renewal.

08-Aug-16
$1.5 billion
canada.gif
Target: 

Whistler Blackcomb Holdings Inc.

U.S.A. flag
Acquiror: 
Vail Resorts, Inc.

Advised Whistler Blackcomb Holdings Inc., a 75% owner and operator of the largest and most visited mountain resort in North America, on its sale to Vail Resorts, Inc.

08-Aug-16
$87 million
U.S.A. flag
Target: 

Aquasana, Inc.

U.S.A. flag
Acquiror: 
A. O. Smith Corporation

Advised A. O. Smith Corporation, a leading manufacturer of residential and commercial water heaters and boilers, on the acquisition of Aquasana, a premium water treatment company, from L Catterton

28-Jul-16
$80 million
U.S.A. flag
Target: 

BioD, LLC

U.S.A. flag
Acquiror: 
Derma Sciences, Inc.

Advised Derma Sciences, Inc., a tissue regeneration company focused on advanced wound and burn care, on the acquisition of a proprietary regenerative medicine products company BioD, LLC and a concurrent private placement.

08-Jul-16
$555 million
U.S.A. flag
Target: 

New Enterprise Stone & Lime Co., Inc.

flag not available

Advised New Enterprise Stone & Lime Co., Inc. on $555 million of secured financings, including a new $450 million senior secured term loan and substantial amendments to its existing $105 million ABL revolver

28-Jun-16
$NA
israel.gif
Target: 

U.S. rights to an authorized generic version of Adderall XR

U.S.A. flag
Acquiror: 
Prasco Laboratories

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights  to an authorized generic version of Adderall XR

28-Jun-16
$652 million
israel.gif
Target: 

U.S. rights to 37 approved and 5 pipeline generic products

australia.gif
Acquiror: 
Mayne Pharma Group Limited

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights  to 42 generic products

27-Jun-16
$156 million
U.S.A. flag
Target: 

ReachLocal

U.S.A. flag
Acquiror: 
Gannett

Served as independent financial advisor to the Board of Directors of Gannett in connection with its acquisition of ReachLocal

21-Jun-16
$586 million
israel.gif
Target: 

U.S. rights to a broad portfolio of 18 generic products from Teva Pharmaceutical Industries Ltd.

U.S.A. flag
Acquiror: 
Impax Laboratories, Inc.

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to a broad portfolio of 18 generic products to Impax Laboratories, Inc.

20-Jun-16
$NA
israel.gif
Target: 

U.S. rights to 2 generic drug products from Teva Pharmaceutical Industries Ltd.

india.gif
Acquiror: 
Zydus Cadila

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to 2 generic drug products to Zydus Cadila

17-Jun-16
$310 million
uk.gif
Target: 

Dobbies Garden Centres

uk.gif
Acquiror: 
Investor group led by Midlothian Capital Partners and Hattington Capital

Advised Tesco plc, a listed FTSE 100 retailer, on its sale of Dobbies Garden Centres to an investor group led by Midlothian Capital Partners and Hattington Capital

16-Jun-16
$40 million
israel.gif
Target: 

U.S. rights to 5 generic injectable drug products from Teva Pharmaceutical Industries Ltd.

U.S.A. flag
Acquiror: 
Sagent Pharmaceuticals, Inc.

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to 5 generic injectable drug products  to Sagent Pharmaceuticals, Inc. 

15-Jun-16
$414 million
U.S.A. flag
Target: 

Aegerion Pharmaceuticals

canada.gif
Acquiror: 
QLT Inc.

Advised QLT Inc. on its merger with Aegerion Pharmaceuticals and concurrent equity raise to create a rare disease-focused global biopharmaceutical organization

11-Jun-16
$350 million
israel.gif
Target: 

U.S. rights to 8 generic drug products from Teva Pharmaceutical Industries Ltd.

india.gif
Acquiror: 
Dr. Reddy’s Laboratories

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to 8 generic drug products to Dr. Reddy’s Laboratories

10-Jun-16
$NA
uk.gif
Target: 

Giraffe restaurants

uk.gif
Acquiror: 
Boparan Private Office

Advised Tesco plc, a listed FTSE 100 retailer, on its sale of the Giraffe casual dining restaurant chain to the Boparan Private Office, the private investment vehicle of the British businessman Ranjit Boparan

01-Jun-16
$221 million
australia.gif
Target: 

Patties Foods Ltd

australia.gif
Acquiror: 
Pacific Equity Partners

Advising Patties Foods Ltd (ASX:PFL), the leading Australian branded frozen food Company, with market leadership in the frozen savoury and frozen dessert segments, on its proposed sale to Pacific Equity Partners via Scheme of Arrangement

26-May-16
$500 million
Egypt, U.S. flags
Target: 

Apex International Energy Management LLC

flag not available

Advised Apex International Energy Management, a newly formed oil and gas venture focused on the Middle East and North Africa regions, in the private equity fund-raising process with multiple energy-focused financial sponsors, ultimately resulting in an initial $500 million capital commitment from Warburg Pincus.

Pages

show all